These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33632966)

  • 41. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. After A COVID-19 Vaccine: Collaboration Or Competition?
    Meyer H
    Health Aff (Millwood); 2020 Nov; 39(11):1856-1860. PubMed ID: 32986500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of the COVID-19 Pandemic on Administration of Adult Vaccinations.
    Corbett S
    N C Med J; 2021; 82(2):126-129. PubMed ID: 33649129
    [No Abstract]   [Full Text] [Related]  

  • 44. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
    McPartlin SO; Morrison J; Rohrig A; Weijer C
    BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
    [No Abstract]   [Full Text] [Related]  

  • 45. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    Trogen B; Oshinsky D; Caplan A
    JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
    [No Abstract]   [Full Text] [Related]  

  • 46. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
    Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1922-1924. PubMed ID: 33332292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 vaccine development: a pediatric perspective.
    Kamidani S; Rostad CA; Anderson EJ
    Curr Opin Pediatr; 2021 Feb; 33(1):144-151. PubMed ID: 33278108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defer vaccination of people who have had covid-19.
    Bhopal R
    BMJ; 2021 Feb; 372():n465. PubMed ID: 33619168
    [No Abstract]   [Full Text] [Related]  

  • 51. Challenges of COVID-19 Vaccination in Iran: In the Fourth Wave of Pandemic Spread.
    Heidari M; Jafari H
    Prehosp Disaster Med; 2021 Oct; 36(5):659-660. PubMed ID: 34287113
    [No Abstract]   [Full Text] [Related]  

  • 52. Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Sep; 383(11):e88. PubMed ID: 32905696
    [No Abstract]   [Full Text] [Related]  

  • 53. Planning for a COVID-19 Vaccination Program.
    Schaffer DeRoo S; Pudalov NJ; Fu LY
    JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155
    [No Abstract]   [Full Text] [Related]  

  • 54. Emergency department-based COVID-19 vaccination: Where do we stand?
    Waxman MJ; Moschella P; Duber HC; Martin DR; Benzoni T; Rothman RE; Schechter-Perkins EM
    Acad Emerg Med; 2021 Jun; 28(6):707-709. PubMed ID: 33825244
    [No Abstract]   [Full Text] [Related]  

  • 55. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lodge A
    Lancet; 2020 Nov; 396(10261):1486. PubMed ID: 33160564
    [No Abstract]   [Full Text] [Related]  

  • 56. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Chauhan A; Agarwal A; Jaiswal N; Singh M
    Lancet; 2020 Nov; 396(10261):1485-1486. PubMed ID: 33160563
    [No Abstract]   [Full Text] [Related]  

  • 57. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.
    Flanagan KL; Best E; Crawford NW; Giles M; Koirala A; Macartney K; Russell F; Teh BW; Wen SC
    Front Immunol; 2020; 11():579250. PubMed ID: 33123165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
    Ma C; Su S; Wang J; Wei L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):245-253. PubMed ID: 32437926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.